Trella Health Resources

Vital Care Infusion Services is a fast-growing infusion management organization built on a franchise model that combines entrepreneurship at a national scale with deep community-level presence. For over 40 years they have been dedicated to expanding access to high-quality infusion therapy and driving better patient outcomes by providing local, safe, convenient, and professional infusion services. With over 160 franchise locations across the country, Vital Care […]

Join Alex Chesnutt, Senior Product Manager, and Josh Price, Senior Solution Engineer, for an inside look at how Trella CRM is redefining sales coaching and why it should be a core part of every sales manager’s workflow.  With the Sales Coaching feature within Trella CRM, sales managers can provide structured feedback, conversation analytics, and real-time coaching to help sales teams improve […]

This blog explores why modern goal setting needs to be embedded directly into sales workflows and how Trella Health’s CRM Goals feature helps healthcare organizations create, track, and manage goals that drive measurable results. In post-acute, HME, DME, and infusion sales, performance management has always depended on clear goals. Sales leaders need to know whether […]

*Note about FFS admissions data:FFS home health, hospice, and skilled nursing admissions are based on claims initially released by CMS to their virtual research data center and accessible by Trella Health. As such, the true number of admissions could be higher when claims that were filed after the initial release are factored in. Trella Health […]

Referrals are a critical driver of growth for infusion providers, but not all referral relationships deliver the same value. In an environment defined by complex therapies, strict payer requirements, and increasing competition, infusion organizations need a more strategic approach to identifying and engaging the referral sources that truly drive sustainable patient volume.  In this session, join Alexis […]

CMS’ recent moratoriums on new home health and hospice agency enrollments have brought renewed attention to provider growth, market saturation, and fraud risk across the country. This interactive map visualizes newly enumerated home health and hospice agency NPIs eligible to bill Medicare, helping healthcare leaders explore where agency growth has accelerated by geography and time […]

Infusion providers are under increasing pressure to grow efficiently in a competitive, high-cost environment. As infusion therapy expands due to clinical innovation, an aging population, and the shift toward outpatient and home-based care, infusion services are becoming a crucial component of modern healthcare delivery. Traditional strategies built on referral volume and relationship-based outreach are no […]

In post-acute care, growth strategies have long relied on a familiar toolkit: spreadsheets, fragmented data sources, and institutional knowledge built over years of relationship management. While these methods once served as a foundation for decision-making, they are increasingly outpaced by the complexity of today’s healthcare landscape, where organizations face challenges such as increased administrative burden […]

Infusion sales teams often rely on outdated referral lists and assumptions, missing high-volume prescribers and losing market share. This blog explores the cost of targeting the wrong physicians and how claims-based medical and pharmacy data reveals real prescribing activity, competitive relationships, and growth opportunities.  What Is the “Infusion Referral Blind Spot”? The infusion referral blind […]

As healthcare shifts further into value-based models, care transitions are emerging as one of the most critical and controllable drivers of both cost and patient outcomes. With the Transforming Episode Accountability Model (TEAM) now in effect as of January 1, 2026, hospitals are facing a new level of accountability that extends well beyond the inpatient stay.  A joint analysis […]

The CY 2027 Final Rule marks a pivotal change in Medicare Advantage and Part D. By removing 11 administrative Star Rating measures and prioritizing clinical outcomes and patient experience, CMS is redefining how plan performance is evaluated. Combined with codification of the Inflation Reduction Act Part D redesign, these changes reshape incentives across the ecosystem. […]

CMS is reshaping the hospice landscape with a proposed 2.4% payment increase, new public reporting measures, and a first-of-its-kind oversight tool: the Service & Spending Variation Index (SSVI). With nearly 20% of hospices currently non-compliant with HQRP, transparency and accountability are taking center stage. Public-facing scores, expanded compliance disclosures, and new beneficiary protections signal a […]